Get the Stockscreener App
60.57
2.95%
1.735
After Hours:
60.57
Twist Bioscience Corp stock is traded at $60.57, with a volume of 1.62M.
It is up +2.95% in the last 24 hours and down -4.16% over the past month.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
See More
Previous Close:
$58.84
Open:
$58.53
24h Volume:
1.62M
Relative Volume:
1.28
Market Cap:
$3.77B
Revenue:
$409.48M
Net Income/Loss:
$-81.28M
P/E Ratio:
-45.59
EPS:
-1.3286
Net Cash Flow:
$-95.14M
1W Performance:
+23.18%
1M Performance:
-4.16%
6M Performance:
+112.08%
1Y Performance:
+115.09%
1-Day Range:
$56.38
$61.95
1-Week Range:
$48.03
$61.95
52-Week Range:
$23.30
$66.06
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
60.57 | 3.66B | 409.48M | -81.28M | -95.14M | -1.3286 |
TMO
Thermo Fisher Scientific Inc
|
448.28 | 167.00B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.00 | 122.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
559.37 | 43.63B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
342.37 | 33.48B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.96 | 32.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Initiated | Stephens | Overweight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience Corp Investor Day Transcript - GuruFocus
Twist Bioscience Corporation (TWST) Expands its Clonal Gene Offering to Include Long and Complex Sequences - Insider Monkey
Leerink raises Twist Bioscience stock price target on AI growth outlook - Investing.com
TWST Stock Price, Quote & Chart | TWIST BIOSCIENCE CORP (NASDAQ:TWST) - ChartMill
Paula Green sells shares; TWST (NASDAQ: TWST) Form 144 lists vesting - Stock Titan
Adam Laponis files sale notice for TWST (NASDAQ: TWST) including recent trades - Stock Titan
TWST insider sales: 6,888 shares vesting; Leproust sold 7,205 and 8,061 shares (TWST) - Stock Titan
Director proposes sale of 1,642 TWST shares in Form 144 (NASDAQ: TWST) - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider files to sell 688 shares - Stock Titan
TWST (NASDAQ: TWST) proposed sale of 4,160 common shares (Form 144) - Stock Titan
Twist Bioscience CorporationCommon Stock (NQ: TWST - FinancialContent
Twist Bioscience Corp stock (US90130A1016): biotech shares under pressure despite fresh AI drug disc - AD HOC NEWS
Twist Bioscience Corporation $TWST Stock Position Lowered by Thrivent Financial for Lutherans - MarketBeat
Twist Bioscience (TWST) price target increased by 20.55% to 64.90 - MSN
Twist Bioscience director Jan Johannessen sells $673,440 in stock By Investing.com - Investing.com Australia
Twist Bioscience director Jan Johannessen sells $673,440 in stock - Investing.com UK
Twist Bioscience (TWST) director exercises options and sells 12,000 shares - Stock Titan
Twist Bioscience Corp stock (US90130A1016): revenue keeps rising as Cathie Wood trims position - AD HOC NEWS
Twist Bioscience Corporation (TWST) latest stock news and headlines - Yahoo Finance Singapore
Cathie Wood’s ARK sells Twist Bioscience, buys Natera stock By Investing.com - Investing.com South Africa
Cathie Wood’s ARK sells Twist Bioscience, buys Natera stock - Investing.com
Cathie Wood’s ARK sells Twist Bioscience stock, buys Intellia shares By Investing.com - Investing.com Australia
Twist Bioscience chief accounting officer sells $282,186 in stock - Investing.com India
Cathie Wood’s ARK sells Twist Bioscience stock, buys Intellia shares - Investing.com
Twist Bioscience chief accounting officer sells $282,186 in stock By Investing.com - Investing.com Canada
Twist Bioscience (TWST) CAO sells 4,961 shares in open-market trade - Stock Titan
Assessing Twist Bioscience (TWST) Valuation After Strong Recent Momentum And Mixed Fair Value Signals - Yahoo Finance
[144] Twist Bioscience Corp SEC Filing - Stock Titan
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results - Insider Monkey
Number of shareholders of Twist Bioscience Corp. – MIL:1TWST - TradingView
TWST (TWST) affiliate Robert F. Werner reports three small resales - Stock Titan
LenioBio and Twist Bioscience Enter into a Collaboration to Further Enable AI drug-discovery - Yahoo Finance
Twist Bioscience Corp (TWST) Climbed on Earnings Beat - Insider Monkey
Twist Bioscience Corp. (TWST) Rallied on Record-Breaking Quarterly Report - Insider Monkey
MSN Money - MSN
Did Twist’s Upbeat Revenue Guidance and Complex Genes Launch Just Shift Twist Bioscience's (TWST) Investment Narrative? - Yahoo Finance
William Blair LLC discloses 8.6% stake in Twist Bioscience (NASDAQ: TWST) - Stock Titan
Twist Bioscience SEC Filings - Stock Titan
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):